Deflazacort API: Micronized & Injectable Manufacturing

Deflazacort is a systemic glucocorticoid and an oxazoline derivative of prednisolone with potent anti-inflammatory and immunosuppressive activity. It is the primary therapeutic agent used in the management of Duchenne Muscular Dystrophy (DMD), where it helps maintain muscle strength and respiratory function in pediatric patients.

At Micro Orgo Chem (MOC), we manufacture Deflazacort in our GMP certified facility. Recognizing that formulation stability is paramount for pediatric oral suspensions, we offer specialized Micronized Grades with precision-controlled Particle Size Distribution (PSD). We also provide a validated Injectable Grade for advanced clinical R&D.

Our API is compliant with USP, IP, and IHS standards, supported by comprehensive stability data and regulatory dossiers.